You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中藥板塊大幅走高 片仔癀漲超6%
格隆匯7月19日丨中藥板塊大幅走高,精華製藥拉昇封板,廣譽遠逼近漲停,中恆集團漲超7%,吉藥控股、同仁堂、片仔癀、九芝堂、隴神戎發漲超6%,新光藥業、亞寶藥業、中新藥業等跟漲。近日國家發改委發佈消息稱,四部門於近日共同編制《“十四五”優質高效醫療衞生服務體系建設實施方案》提出,到2025年,建設30個左右國家中醫藥傳承創新中心,重點提升中醫藥基礎研究、優勢病種診療、高層次人才培養、中醫藥裝備和中藥新藥研發、科技成果轉化等能力。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account